Key result
Prior anxiety disorders in adult CHD are linked to ~14% higher depressive symptom severity.
Why the study?
Adults with congenital heart disease may experience substantial psychological distress, and it remained to be evaluated whether a documented history of anxiety disorders is associated with a distinct psychosocial profile.
Is a documented history of anxiety disorders associated with a worse psychosocial profile (depressive symptom severity, trait anxiety, self-esteem, and self-rated health) in adults with congenital heart disease?
Cross-Sectional (n=45)
No
Is a documented history of anxiety disorders associated with a worse psychosocial profile (depressive symptom severity, trait anxiety, self-esteem, and self-rated health) in adults with congenital heart disease?
Odds Ratio: 1.14 (95% CI 1.05–1.28)
Absolute Event Rate: 19% vs 3%
p-value: p=0.011
In adults with congenital heart disease, a documented history of anxiety disorders is independently associated with greater depressive symptom severity and poorer self-rated health, highlighting the clinical utility of reviewing psychiatric history to identify vulnerable patients.
May flag higher-risk adults with CHD for closer psychosocial monitoring; hypothesis-generating and should not yet change practice.
Background Adults with congenital heart disease (CHD) may experience substantial psychological distress. This study evaluated whether a documented history of anxiety disorders is associated with a distinct psychosocial profile in adults with CHD. Methods In this cross-sectional study, 45 adults with CHD were included: 21 with a documented history of anxiety disorders and 24 without. Psychosocial assessment included the EuroQol-5D-3L (EQ-5D-3L), Rosenberg Self-Esteem Scale (RSES), State–Trait Anxiety Inventory (STAI), and Beck Depression Inventory-II (BDI-II). Associations between psychosocial measures and documented anxiety history were assessed using multivariable logistic regression adjusted for sex, NYHA functional class, and CHD complexity. Moderate depression was additionally assessed using univariable logistic regression. Results Mean age was 35 ± 9 years in participants with a documented history of anxiety disorders and 31 ± 11 years in those without ( P = 0.230); males accounted for 33% and 62%, respectively ( P = 0.052). NYHA functional class II–IV was more frequent among participants with a documented history of anxiety disorders (67% vs. 25%; P = 0.018). Compared with those without a documented anxiety history, participants with anxiety history reported greater limitations in usual activities ( P = 0.021), higher anxiety/depression scores on the EQ-5D-3L ( P = 0.023), poorer self-rated health ( P = 0.038), higher trait anxiety (31.2 ± 5.8 vs. 26.5 ± 5.2; P = 0.008), and greater depressive symptom severity (BDI-II median 19 vs. 3; P = 0.001). Self-esteem was also higher (RSES median 27 vs. 25; P = 0.006). After adjustment, BDI-II scores were positively associated with a documented history of anxiety disorders (OR 1.14, 95% CI 1.05–1.28; P = 0.011), while EQ-5D VAS scores were inversely associated (OR 0.64, 95% CI 0.38–0.97; P = 0.048). STAI-State, STAI-Trait, and RSES scores were not significantly associated with anxiety history. None of the variables assessed in the univariable analysis was significantly associated with moderate depression. Conclusions In adults with CHD, a documented history of anxiety disorders was associated with greater depressive symptom severity and poorer self-rated health after adjustment for relevant clinical factors.
No takes yet. Share an insight, caveat, or question.
Martínez‐Quintana et al. (2026) conducted a cross-sectional in Congenital heart disease (n=45). Documented history of anxiety disorders vs. No documented history of anxiety disorders and no prior use of anxiolytic medication was evaluated on Depressive symptom severity (Beck Depression Inventory-II score) (OR 1.14, 95% CI 1.05-1.28, p=0.011). A documented history of anxiety disorders in adults with CHD was independently associated with greater depressive symptom severity (BDI-II OR 1.14, p=0.011) and poorer self-rated health (OR 0.64).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: